-+ 0.00%
-+ 0.00%
-+ 0.00%

Apimeds Pharmaceuticals Q4 EPS $(0.80) Down From $(0.50) YoY

Benzinga·05/04/2026 13:36:45
Listen to the news
Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(0.80) per share. This is a 60 percent decrease over losses of $(0.50) per share from the same period last year.